{
  "trial_id": "NCT00461149",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "newly diagnosed acromegaly",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "age above 18 years",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "no previous treatments for acromegaly",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "primary surgery",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "concomitant hyperprolactinemia if requiring combined treatment with dopamine-agonist",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "primary treatment with lanreotide",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "treatment duration less than 24 months",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has newly diagnosed acromegaly, is above 18 years old and has not received previous treatments for the condition. However, treatment details are unclear.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT00461149",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}